Cellular response to peptidoglycan

pathway activity — cross-omics
GO:0071224Cross-omicsPROTEIN-MS → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Cellular response to peptidoglycan pathway is significantly associated with the protein abundance of multiple proteins, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are RIPK2, RIPK2_S363, and TCEAL4, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Cellular response to peptidoglycan activity versus RIPK2 in BRCA (Pearson r = 0.10).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCARIPK2 →+0.412+0.347<.001.00135
LUADRIPK2_S363 →+0.681+0.729<.001<.00126
BRCATCEAL4 →-0.638-0.428<.001<.00134
UCECSH3D21_S452 →+1.741+1.725<.001<.00133
LUADRAP1GAP_S515 →-1.046-0.567<.001<.00133
PDACRIPK2_S393 →+0.870+0.859<.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0071224 vs RIPK2 — BRCA

Per-sample scatter of Cellular response to peptidoglycan activity vs RIPK2 in BRCA.

Explore this scatter interactively →

Exploration